- Home
- CPAC vs FULC Comparison
CPAC vs FULC Comparison
Compare CPAC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPAC | FULC |
|---|---|---|
| Founded | 1949 | 2015 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 580.5M | 468.1M |
| IPO Year | 2012 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CPAC | FULC |
|---|---|---|
| Price | $6.81 | $9.08 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.95 | ★ $12.71 |
| AVG Volume (30 Days) | 28.0K | ★ 860.3K |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | ★ 8.09% | N/A |
| EPS Growth | ★ 20.27 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $601,081,883.00 | N/A |
| Revenue This Year | $9.96 | N/A |
| Revenue Next Year | $1.70 | N/A |
| P/E Ratio | $8.63 | ★ N/A |
| Revenue Growth | 6.18 | ★ 2752.05 |
| 52 Week Low | $5.10 | $2.32 |
| 52 Week High | $7.57 | $12.19 |
Technical Indicators
Market Signals| Indicator | CPAC | FULC |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 44.04 |
| Support Level | $6.61 | $10.75 |
| Resistance Level | $6.85 | $12.05 |
| Average True Range (ATR) | 0.25 | 0.94 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 45.60 | 11.80 |
Price Performance
Historical ComparisonAbout CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.